Skip to main content

Advertisement

Murine leukemia virus RNA dimerization is coupled to transcription and splicing processes

Article metrics

Abstract

Most of the cell biological aspects of retroviral genome dimerization remain unknown. Murine leukemia virus (MLV) constitutes a useful model to study when and where dimerization occurs within the cell. For instance, MLV produces a subgenomic RNA (called SD') that is co-packaged with the genomic RNA predominantly as FLSD' heterodimers. This SD' RNA is generated by splicing of the genomic RNA and also by direct transcription of a splice-associated retroelement of MLV (SDARE). We took advantage of these two SD' origins to study the effects of transcription and splicing events on RNA dimerization. Using genetic approaches coupled to capture of RNA heterodimer in virions, we determined heterodimerization frequencies in different cellular contexts. Several cell lines were stably established in which SD' RNA was produced by either splicing or transcription from SDARE. Moreover, SDARE was integrated into the host chromosome either concomitantly or sequentially with the genomic provirus. Our results showed that transcribed genomic and SD' RNAs preferentially formed heterodimers when their respective proviruses were integrated together. In contrast, heterodimerization was strongly affected when the two proviruses were integrated independently. Finally, dimerization was enhanced when the transcription sites were expected to be physically close. For the first time, we report that splicing and RNA dimerization appear to be coupled. Indeed, when the RNAs underwent splicing, the FLSD' dimerization reached a frequency similar to co-transcriptional heterodimerization. Altogether, our results indicate that randomness of heterodimerization increases when RNAs are co-expressed during either transcription or splicing. Our results strongly support the notion that dimerization occurs in the nucleus, at or near the transcription and splicing sites, at areas of high viral RNA concentration.

Findings

The dimeric nature of the genome is strongly conserved among Retroviridae, underlying the importance of RNA dimerization for virus replication. Packaging of two genome copies increases the probability of recombination events by template switching upon the reverse transcription, thus promoting genetic diversity [1]. Dimerization may play an additional role in the sorting of the viral full-length RNA (FL RNA) between different fates, including splicing, translation, and packaging [2]. RNA structural switches induced by dimerization might be responsible for such RNA versatility [38]. Dimerization and packaging of MLV unspliced RNAs are well documented with identification of the RNA cis-element (Psi) and its interaction with the trans-acting Gag factor [6, 918]. Dimerization appears to be a prerequisite for genomic RNA packaging [19] and could participate in the selection of the genome among a multitude of cellular and viral mRNAs. However, where and when RNA dimerization occurs in cell have long remained unresolved [1921], and constitute the aims of the present study.

Presumably, dimerization occurs in the cell prior to RNA packaging as supported by recent microscopy studies at single-RNA-detection sensitivity [22, 23]. Moreover, the co-localization of Gag and FL RNA in the nucleus suggests that Gag might bind the FL RNA inside the nucleus [2426]. Such a connection between Gag nuclear trafficking and genome packaging provides an attractive model for how retroviruses first recruit their genomes. The consequence of the nuclear RNA life on RNA packaging and presumably on RNA dimerization is also supported by genetic approaches [2730]. For instance, transcription of two MLV RNAs expressed from a single locus favored their co-packaging while transcription from distant loci did not. Here, we undertook the same genetic approaches coupled with virion RNA capture assays (RCA) to determine whether transcription and splicing steps could impact RNA dimerization efficiency. We took advantage of a unique characteristic of MLV to produce a splice-associated retroelement (SDARE) [31].

In addition to the env mRNA, MLV produces an alternatively spliced 4.4-Kb RNA, called SD' RNA (Figure 1A). This alternative splicing recruits a splice donor site, SD', which is conserved among types C and D mammalian oncoretroviruses. Intact SD' is required for optimal virus replication and pathogenesis [3235]. During the MLV life cycle, the SD' RNA shares all the characteristics of the FL RNA, since it goes through encapsidation, reverse transcription and integration steps. It acts as a defective retroelement (SDARE) that enables SD' RNA production via direct transcription by the cellular machinery, without the need for a splicing step [31]. Therefore, the SD' RNA can be generated via two different pathways, either by splicing of the FL RNA (splSD') or by direct transcription of SDARE (trSD').

Figure 1
figure1

Schematic representation of viral constructs and RNA expression. The dimerization/packaging signal, Psi, is contained in all RNAs. (A) The pFL plasmid corresponds to Mo-MLV molecular clone (pBSKeco, a kind gift from FL.Cosset [59]) and generates FL RNA after transcription. The SD' RNA derives from splicing between an alternative splice donor site, designated SD', located within the gag gene, and the canonical splice acceptor site (SA). (B) The pFL* mutant contained three nucleotide substitutions in the SD' splice donor site that impaired the alternative splicing. (C) The pSD' plasmid allows prespliced SD' RNA production by direct transcription. After integration in the host genome, pSD' corresponds to SDARE.

The FL and SD' RNAs harbor the same Psi sequence responsible for their co-packaging. In vitro, the two RNAs harbored similar dimerization abilities and formed Psi-dependent heterodimers (FLSD') [36]. Analysis of virion content by RCA revealed that the SD' RNA was co-packaged with the FL RNA predominantly as heterodimeric forms [36]. This preferential dimerization of SD' RNA with FL RNA may influence recombination events since their association could restrict the interaction of FL RNA with other defective endogenous retroviruses or virus-like elements, and may have consequences in MLV pathogenesis [34, 37, 38]. Here, we took advantage of the propensity of the SD' RNA to form FLSD' heterodimers to study the impact of SD' transcription or splicing on MLV RNA dimerization.

Transcription and dimerization

It has been reported that co-packaging of two MLV RNAs was dependent on the distance between their transcription sites [27, 28]. These studies were based on the previous finding that stable co-transfection of two different plasmid DNAs lead to their integration as concatamers whereas a two-step stable transfection lead to two independent integration events [3943]. These two transfection methods were validated for MLV-based vectors carrying different selectable markers. When two different viral RNAs were produced from tandem integrations by the one-step method, local and overlapping accumulation of both RNA transcripts were observed. In contrast, there was no co-localization of the RNAs generated by distinct transcription cassettes in the two-step approach [27, 28].

Here, we investigated whether the link between preferential co-packaging of two MLV RNAs and the proximity of their transcription sites was due to RNA dimerization [30]. To explore this possibility, we used the characteristic of MLV to produce two different proviruses, MLV and SDARE, which generate FL and SD' RNA transcripts, respectively [31]. To prevent the production of SD' RNA by splicing of the FL RNA, we used a mutant MLV carrying an inactive SD' site (pFL*) (Figure 1B). This mutation did not activate cryptic splicing sites and it slightly affected the MLV replication in vitro and in vivo (also called M1 or MSD1 in [32, 34, 35]). We used the same genetic approaches as previously validated, in which spatial positions of MLV proviral transcription sites are modulated by one versus two -step stable transfections [27, 28, 3943]. Stably transfected 293-cell lines were established in which the FL and SD' (trSD') RNAs were transcribed from pFL* and SDARE molecular clone (pSD'), respectively [31] (Figure 1C). The pFL* and pSD' plasmids were transfected together or sequentially to generate integrations in tandem or in distant loci, respectively (Figure 2AB). After selection, resistant colonies were pooled and RNA extracted from total cell extracts. Viral FL and SD' RNAs as well as the GAPDH mRNA were quantified by RT-QPCR as previously described [36]. The results indicate that the trSD' and FL RNAs are equally transcribed in both contexts (Figure 2AB). The quantification of intracellular RNA dimers has long been an unresolved technical problem. Therefore, we measured the heterodimers in released virions, by using RNA Capture Assay (RCA), a tool designated to examine heterodimerization between two distinct RNAs [29]. All RCA steps were previously described for FLSD' heterodimerization analysis and were followed meticulously [36]. The major steps are briefly outlined in Figure 3. The FL RNA is used as a bait that was retained on the magnetic beads via a complementary biotinylated oligonucleotide. The SD' RNA was only captured via its association with FL RNA. Thus, SD' RNA presence in the elution can be used as a measure of heterodimerization. As described previously, the occurrence of heterodimerization was controlled by heat-denaturating the RNA samples before capture, in order to dissociate dimers. SD' RNA was no longer captured in the heat-treated samples [36]. The copy numbers of the FL and SD' RNAs were measured in the virion input and the elution fractions by specific RT-QPCR as previously described [31, 36, 44], and the SD' proportions in input and in elution samples are reported in Table 1. The elution/input ratios calculated for SD' reflect to some extent the heterodimerization efficiencies. Results from the two transfection procedures revealed that heterodimerization was ~30-times more efficient for proviruses integrated simultaneously, and presumably in tandem, than for proviruses integrated independently and likely in different loci.

Table 1 Comparative study of heterodimerization frequencies for SD' RNA produced in the different cellular contexts.
Figure 2
figure2

Experimental strategy to study FLSD' heterodimerization in different cellular contexts. Thick lines correspond to viral proviruses with genomic and SD' templates in blue and red, respectively. (A) One-step stable co-transfection of pFL* and pSD' allows concomitant integration of the two proviruses. Presumably, the transcription sites of the SD' and the FL RNAs are in close proximity on the chromosome. (B) Two-step stable transfections of pFL* and pSD' lead to sequential and independent integration events. SD' RNA is synthesized by transcription of a SDARE integrated in a site distant to that of FL provirus. (C) Stable transfection was performed with the replication-competent MLV molecular clone. SD' RNA is produced by splicing of the FL RNA. For each procedure, levels of the FL and SD' RNAs in stably transfected cells were determined by RT-QPCR. RNA copy numbers (cps) normalized to 106 cps GAPDH mRNA are given in the graphs.

Figure 3
figure3

Study of FLSD' heterodimerization by RNA Capture Assay (RCA). Details of the procedure were provided previously [36]. Briefly, two-days after transfection, RNAs were extracted from both cells and purified virions. An aliquot (1/5) of the RNA sample extracted from released virions was used for the input sample, whereas the rest (4/5) of the RNA sample was subject to the capture assay by using the 3'-biotinylated anti-MLV pol oligonucleotide (5' CAGTCTCTGTATGTGGGGCTTG 3'). Oligonucleotide-bound RNA was recovered by magnetic streptavidin-coated beads by using a magnetic stand. After several washes, the bound RNA was eluted by heating at 85°C for 5 minutes in water (elution sample). RNAs in elution sample were ethanol precipitated with 15 μg of carrier tRNA. Levels of FL and SD' RNAs were determined in cell extract, input and elution samples by specific RT-QPCR [36].

To deduce the distribution of FLSD' heterodimers predicted for random RNA dimerization, we used the Hardy-Weinberg equation, as previously described for MLV RNA dimerization [29]. Predicted heterodimer proportions were compared to those determined experimentally (Table 2, column (3)). The two stably-transfected cell lines strongly differ in randomness of heterodimerization. For integrations in tandem, heterodimers formed at a frequency similar to that predicted from random RNA assortment. In contrast, for independent integrations, FL and SD' RNAs associated according to a non-random distribution, as previously reported [29, 30].

Table 2 Comparison between the predicted and the measured heterodimerization efficiencies.

These findings imply that MLV RNA dimer-partner selection occurs co-transcriptionally or within a pool of transcripts near the proviral templates. Our results correlate with previous studies showing the preferential co-packaging of MLV RNAs transcribed from the same chromosomal site [27, 28]. Our finding indicates that RNA dimerization might be responsible for this preference.

Splicing and dimerization

RNA splicing is spatially and functionally linked to transcription [45]. Therefore, the possibility of a correlation between splicing and dimerization, as already noted above for transcription and dimerization, was investigated. To test this new hypothesis, we determined the FLSD' heterodimerization efficiency with a SD' RNA issued exclusively from splicing (splSD'). Cells were stably transfected with wild-type replication-competent MLV clone (here named pFL) and pcDNA-hygro plasmid (Figure 1A). After transcription, the FL RNA undergoes splicing to generate the SD' RNA. As expected, splSD' RNA was less abundant than FL RNA in these cells (splSD'/FL ratio is 1:50) (Figure 2C). Nevertheless, virion content analysis by RCA showed that spliced splSD' RNA represented 0.1% of total elution leading to a heterodimerization efficiency of 36-42%. Interestingly, this efficiency was similar to that measured for co-expressed trSD' and FL RNAs when their respective DNAs were cotransfected (Table. 1). Likewise, the splSD' and FL RNAs segregated at a frequency close to that predicted from a random distribution (Table. 2).

Such a link between splicing and dimerization provides possible clues to the packaging process of spliced viral RNAs. Although the genomic RNA is preferentially packaged, the subgenomic RNAs are also specifically packaged into infectious HIV and MLV particles, although to a lower extent [31, 4648]. Such co-packaging of spliced and FL RNAs possibly involves heterodimerization. This model is supported by the ability of the MLV SD' spliced RNA to heterodimerize with the genomic RNA [36]. Note that HIV spliced RNAs were also able to dimerize in vitro [49, 50]. It is still not clear how splicing contributes to dimerization. Dimerization might precede and somehow modulate splicing so that only one FL RNA molecule is spliced within FLFL homodimers, leading to asymmetrical dimers (FLSD'). Alternatively, the FL and SD' RNAs could associate during or soon after the splicing process is finished. This latter model correlates with our findings that splicing and co-transcription conferred similar heterodimerization efficiencies, implying the recruitment of a common mechanism for the two pathways.

Altogether our results showed that MLV RNAs preferentially dimerize when they undergo splicing or co-transcription. In contrast, the distance between transcription sites could hinder RNA dimerization. At least two non-exclusive hypotheses could explain these results. Host factors could play a role in dimerization [20, 51]. For instance, transcription or splicing factors may confer a higher accessibility to the 5' end of the RNA including the dimer linkage structure (DLS) and thereby allows for better recognition of the DLS by the RNA partner and/or by Gag. Also, a direct role for an unidentified host candidate cannot be excluded. Similarly, nascent RNAs that are undergoing synthesis might adopt a more favorable conformation for dimerization compared to complete transcripts. In support of this model, dimerization occurred more efficiently for large synthetic MLV or HIV RNAs during in vitro transcription than post-synthesis [30, 36, 49]. Alternatively, co-transcription and splicing could enhance dimerization by providing high local RNA concentration in a subnuclear domain that facilitates RNA-RNA interactions. This mechanism is supported by previous studies showing that MLV RNA dimerization is dependent on RNA concentration in vitro [6, 52]. Furthermore, it correlates with the nuclear accumulation of the viral FL RNA (75%) observed in MLV-producing cells [44].

Our results suggest that viral RNAs dimerize in the nucleus and presumably traffic out of the nucleus as dimers. Importantly, the MLV packaging signal (Psi) which overlaps the DLS, also contributes to nuclear export of the FL RNA [44, 53]. Therefore, dimerization may impact on the RNA export pathway and determine the cytoplasmic fate of the RNA [54]. Dimers would be routed to virus assembly sites and packaged to serve as the viral genome, while monomers would be processed by the translation machinery to encode viral proteins. This would explain the occurrence of two functionally distinct pools of MLV FL RNA [55, 56] and is supported by the nuclear localization of MLV Gag protein [24]. In agreement with this attractive model that we are testing in our laboratory, two articles were published upon completion of our manuscript, concluding that transient nuclear trafficking of Gag is required for RNA encapsidation in RSV or lentiviral particles [57, 58].

References

  1. 1.

    Temin HM: Sex and recombination in retroviruses. Trends Genet. 1991, 7: 71-74.

  2. 2.

    Butsch M, Boris-Lawrie K: Destiny of unspliced retroviral RNA: ribosome and/or virion?. J Virol. 2002, 76: 3089-3094. 10.1128/JVI.76.7.3089-3094.2002.

  3. 3.

    Tounekti N, Mougel M, Roy C, Marquet R, Darlix JL, Paoletti J, Ehresmann B, Ehresmann C: Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J Mol Biol. 1992, 223: 205-220. 10.1016/0022-2836(92)90726-Z.

  4. 4.

    Miyazaki Y, Garcia EL, King SR, Iyalla K, Loeliger K, Starck P, Syed S, Telesnitsky A, Summers MF: An RNA structural switch regulates diploid genome packaging by Moloney murine leukemia virus. J Mol Biol. 396: 141-152. 10.1016/j.jmb.2009.11.033.

  5. 5.

    D'Souza V, Summers MF: Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus. Nature. 2004, 431: 586-590. 10.1038/nature02944.

  6. 6.

    De Tapia M, Metzler V, Mougel M, Ehresmann B, Ehresmann C: Dimerization of MoMuLV genomic RNA: redefinition of the role of the palindromic stem-loop H1 (278-303) and new roles for stem-loops H2 (310- 352) and H3 (355-374). Biochemistry. 1998, 37: 6077-6085. 10.1021/bi9800303.

  7. 7.

    Badorrek CS, Gherghe CM, Weeks KM: Structure of an RNA switch that enforces stringent retroviral genomic RNA dimerization. Proc Natl Acad Sci USA. 2006, 103: 13640-13645. 10.1073/pnas.0606156103.

  8. 8.

    Ooms M, Huthoff H, Russell R, Liang C, Berkhout B: A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J Virol. 2004, 78: 10814-10819. 10.1128/JVI.78.19.10814-10819.2004.

  9. 9.

    Mikkelsen JG, Lund AH, Duch M, Pedersen FS: Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo. J Virol. 2000, 74: 600-610. 10.1128/JVI.74.2.600-610.2000.

  10. 10.

    Housset V, De Rocquigny H, Roques BP, Darlix JL: Basic amino acids flanking the zinc finger of Moloney murine leukemia virus nucleocapsid protein NCp10 are critical for virus infectivity. J Virol. 1993, 67: 2537-2545.

  11. 11.

    Paoletti J, Mougel M, Tounekti N, Girard PM, Ehresmann C, Ehresmann B: Spontaneous dimerization of retroviral MoMuLV RNA. Biochimie. 1993, 75: 681-686. 10.1016/0300-9084(93)90099-E.

  12. 12.

    Hansen M, Jelinek L, Jones RS, Stegeman-Olsen J, Barklis E: Assembly and composition of intracellular particles formed by Moloney murine leukemia virus. J Virol. 1993, 67: 5163-5174.

  13. 13.

    Rasmussen SV, Mikkelsen JG, Pedersen FS: Modulation of homo- and heterodimerization of Harvey sarcoma virus RNA by GACG tetraloops and point mutations in palindromic sequences. J Mol Biol. 2002, 323: 613-628. 10.1016/S0022-2836(02)00966-X.

  14. 14.

    D'Souza V, Melamed J, Habib D, Pullen K, Wallace K, Summers MF: Identification of a high affinity nucleocapsid protein binding element within the Moloney murine leukemia virus Psi-RNA packaging signal: implications for genome recognition. J Mol Biol. 2001, 314: 217-232. 10.1006/jmbi.2001.5139.

  15. 15.

    Torrent C, Bordet T, Darlix JL: Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus. J Mol Biol. 1994, 240: 434-444. 10.1006/jmbi.1994.1459.

  16. 16.

    Mougel M, Zhang Y, Barklis E: Cis-active structural motifs involved in specific encapsidation of Moloney Murine Leukemia Virus RNA. J Virol. 1996, 70: 5043-5050.

  17. 17.

    Hibbert CS, Mirro J, Rein A: mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers. J Virol. 2004, 78: 10927-10938. 10.1128/JVI.78.20.10927-10938.2004.

  18. 18.

    Fisher J, Goff SP: Mutational analysis of stem-loops in the RNA packaging signal of the Moloney murine leukemia virus. Virology. 1998, 244: 133-145. 10.1006/viro.1998.9090.

  19. 19.

    Russell RS, Liang C, Wainberg MA: Is HIV-1 RNA dimerization a prerequisite for packaging? Yes, no, probably?. Retrovirology. 2004, 1: 23-10.1186/1742-4690-1-23.

  20. 20.

    Paillart JC, Shehu-Xhilaga M, Marquet R, Mak J: Dimerization of retroviral RNA genomes: an inseparable pair. Nat Rev Microbiol. 2004, 2: 461-472. 10.1038/nrmicro903.

  21. 21.

    D'Souza V, Summers MF: How retroviruses select their genomes. Nat Rev Microbiol. 2005, 3: 643-655. 10.1038/nrmicro1210.

  22. 22.

    Chen J, Nikolaitchik O, Singh J, Wright A, Bencsics CE, Coffin JM, Ni N, Lockett S, Pathak VK, Hu WS: High efficiency of HIV-1 genomic RNA packaging and heterozygote formation revealed by single virion analysis. Proc Natl Acad Sci USA. 2009, 106: 13535-13540. 10.1073/pnas.0906822106.

  23. 23.

    Jouvenet N, Simon SM, Bieniasz PD: Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc Natl Acad Sci USA. 2009, 106: 19114-19119. 10.1073/pnas.0907364106.

  24. 24.

    Nash MA, Meyer MK, Decker GL, Arlinghaus RB: A subset of Pr65gag is nucleus associated in murine leukemia virus-infected cells. J Virol. 1993, 67: 1350-1356.

  25. 25.

    Dupont S, Sharova N, DeHoratius C, Virbasius CM, Zhu X, Bukrinskaya AG, Stevenson M, Green MR: A novel nuclear export activity in HIV-1 matrix protein required for viral replication. Nature. 1999, 402: 681-685. 10.1038/45272.

  26. 26.

    Garbitt-Hirst R, Kenney SP, Parent LJ: Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging. J Virol. 2009, 83: 6790-6797. 10.1128/JVI.00101-09.

  27. 27.

    Kharytonchyk SA, Kireyeva AI, Osipovich AB, Fomin IK: Evidence for preferential copackaging of Moloney murine leukemia virus genomic RNAs transcribed in the same chromosomal site. Retrovirology. 2005, 2: 3-10.1186/1742-4690-2-3.

  28. 28.

    Rasmussen SV, Pedersen FS: Co-localization of gammaretroviral RNAs at their transcription site favours co-packaging. J Gen Virol. 2006, 87: 2279-2289. 10.1099/vir.0.81759-0.

  29. 29.

    Flynn JA, An W, King SR, Telesnitsky A: Nonrandom dimerization of murine leukemia virus genomic RNAs. J Virol. 2004, 78: 12129-12139. 10.1128/JVI.78.22.12129-12139.2004.

  30. 30.

    Flynn JA, Telesnitsky A: Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random. Virology. 2006, 344: 391-400. 10.1016/j.virol.2005.09.002.

  31. 31.

    Houzet L, Battini JL, Bernard E, Thibert V, Mougel M: A new retroelement constituted by a natural alternatively spliced RNA of murine replication-competent retroviruses. EMBO J. 2003, 22: 4866-4875. 10.1093/emboj/cdg450.

  32. 32.

    Dejardin J, Bompard-Marechal G, Audit M, Hope TJ, Sitbon M, Mougel M: A Novel Subgenomic Murine Leukemia Virus RNA Transcript Results from Alternative Splicing. J Virol. 2000, 74: 3709-3714. 10.1128/JVI.74.8.3709-3714.2000.

  33. 33.

    Mukhopadhyaya R, Wolff L: New sites of integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation. J Virol. 1992, 66: 6035-6044.

  34. 34.

    Ramirez JM, Houzet L, Koller R, Bies J, Wolff L, Mougel M: Activation of c-myb by 5' retrovirus promoter insertion in myeloid neoplasms is dependent upon an intact alternative splice donor site (SD') in gag. Virology. 2004, 330: 398-407. 10.1016/j.virol.2004.09.038.

  35. 35.

    Audit M, Dejardin J, Hohl B, Sidobre C, Hope TJ, Mougel M, Sitbon M: Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties. J Virol. 1999, 73: 10472-10479.

  36. 36.

    Maurel S, Houzet L, Garcia EL, Telesnitsky A, Mougel M: Characterization of a natural heterodimer between MLV genomic RNA and the SD' retroelement generated by alternative splicing. RNA. 2007, 13: 2266-2276. 10.1261/rna.713807.

  37. 37.

    Muriaux D, Rein A: Encapsidation and transduction of cellular genes by retroviruses. Front Biosci. 2003, 8: D135-142. 10.2741/950.

  38. 38.

    Moore MD, Fu W, Nikolaitchik O, Chen J, Ptak RG, Hu WS: Dimer initiation signal of human immunodeficiency virus type 1: its role in partner selection during RNA copackaging and its effects on recombination. J Virol. 2007, 81: 4002-4011. 10.1128/JVI.02589-06.

  39. 39.

    Chen C, Chasin LA: Cointegration of DNA molecules introduced into mammalian cells by electroporation. Somat Cell Mol Genet. 1998, 24: 249-256. 10.1023/B:SCAM.0000007127.80657.10.

  40. 40.

    Perucho M, Hanahan D, Wigler M: Genetic and physical linkage of exogenous sequences in transformed cells. Cell. 1980, 22: 309-317. 10.1016/0092-8674(80)90178-6.

  41. 41.

    Goff SP, Tabin CJ, Wang JY, Weinberg R, Baltimore D: Transfection of fibroblasts by cloned Abelson murine leukemia virus DNA and recovery of transmissible virus by recombination with helper virus. J Virol. 1982, 41: 271-285.

  42. 42.

    Goldfarb MP, Weinberg RA: Structure of the provirus within NIH 3T3 cells transfected with Harvey sarcoma virus DNA. J Virol. 1981, 38: 125-135.

  43. 43.

    Wang ML, Lee AS: Polymerization of vector DNA after transfection into hamster fibroblast cells. Biochem Biophys Res Commun. 1983, 110: 593-601. 10.1016/0006-291X(83)91191-9.

  44. 44.

    Smagulova F, Maurel S, Morichaud Z, Devaux C, Mougel M, Houzet L: The highly structured encapsidation signal of MuLV RNA is involved in the nuclear export of its unspliced RNA. J Mol Biol. 2005, 354: 1118-1128. 10.1016/j.jmb.2005.10.021.

  45. 45.

    Szentirmay MN, Sawadogo M: Spatial organization of RNA polymerase II transcription in the nucleus. Nucleic Acids Res. 2000, 28: 2019-2025. 10.1093/nar/28.10.2019.

  46. 46.

    Houzet L, Paillart JC, Smagulova F, Maurel S, Morichaud Z, Marquet R, Mougel M: HIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms. Nucleic Acids Res. 2007, 35: 2695-2704. 10.1093/nar/gkm153.

  47. 47.

    Houzet L, Morichaud Z, Mougel M: Fully-spliced HIV-1 RNAs are reverse transcribed with similar efficiencies as the genomic RNA in virions and cells, but more efficiently in AZT-treated cells. Retrovirology. 2007, 4: 30-10.1186/1742-4690-4-30.

  48. 48.

    Liang C, Hu J, Russell RS, Kameoka M, Wainberg MA: Spliced human immunodeficiency virus type 1 RNA is reverse transcribed into cDNA within infected cells. AIDS Res Hum Retroviruses. 2004, 20: 203-211. 10.1089/088922204773004923.

  49. 49.

    Sinck L, Richer D, Howard J, Alexander M, Purcell DF, Marquet R, Paillart JC: In vitro dimerization of human immunodeficiency virus type 1 (HIV-1) spliced RNAs. RNA. 2007, 13: 2141-2150. 10.1261/rna.678307.

  50. 50.

    Lanchy JM, Szafran QN, Lodmell JS: Splicing affects presentation of RNA dimerization signals in HIV-2 in vitro. Nucleic Acids Res. 2004, 32: 4585-4595. 10.1093/nar/gkh800.

  51. 51.

    Moore MD, Hu WS: HIV-1 RNA dimerization: It takes two to tango. AIDS Rev. 2009, 11: 91-102.

  52. 52.

    Oroudjev EM, Kang PC, Kohlstaedt LA: An additional dimer linkage structure in Moloney murine leukemia virus RNA. J Mol Biol. 1999, 291: 603-613. 10.1006/jmbi.1999.2984.

  53. 53.

    Basyuk E, Boulon S, Skou Pedersen F, Bertrand E, Vestergaard Rasmussen S: The packaging signal of MLV is an integrated module that mediates intracellular transport of genomic RNAs. J Mol Biol. 2005, 354: 330-339. 10.1016/j.jmb.2005.09.071.

  54. 54.

    Stutz F, Izaurralde E: The interplay of nuclear mRNP assembly, mRNA surveillance and export. Trends Cell Biol. 2003, 13: 319-327. 10.1016/S0962-8924(03)00106-5.

  55. 55.

    Dorman N, Lever A: Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus. J Virol. 2000, 74: 11413-11417. 10.1128/JVI.74.23.11413-11417.2000.

  56. 56.

    Levin JG, Rosenak MJ: Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc Natl Acad Sci USA. 1976, 73: 1154-1158. 10.1073/pnas.73.4.1154.

  57. 57.

    Gudleski N, Flanagan JM, Ryan EP, Bewley MC, Parent LJ: Directionality of nucleocytoplasmic transport of the retroviral gag protein depends on sequential binding of karyopherins and viral RNA. Proc Natl Acad Sci USA. 2010, 107: 9358-9363. 10.1073/pnas.1000304107.

  58. 58.

    Kemler I, Meehan A, Poeschla EM: Live-cell coimaging of the genomic RNAs and Gag proteins of two lentiviruses. J Virol. 2010, 84: 6352-6366. 10.1128/JVI.00363-10.

  59. 59.

    Shinnick TM, Lerner RA, Sutcliffe JG: Nucleotide sequence of Moloney murine leukaemia virus. Nature. 1981, 293: 543-548. 10.1038/293543a0.

Download references

Acknowledgements

We thank laboratory members past and present, including Laurent Houzet, Fatima Smagulova, and Zakia Morichaud for help and advice throughout this work. Special thanks to Laurent Houzet for constant interest and helpful comments on the manuscript. We thank Drs. R. Kiernan and C. Jacqué-O'Reilly for the critical reading of the manuscript. This work was supported by ACI/ANR grant and by CNRS. SM was supported by a fellowship from ACI/ANR.

Author information

Correspondence to Marylène Mougel.

Additional information

Authors' contributions

SM and MM conceived the study and analyzed the data. SM performed the laboratory work. MM wrote the manuscript. The authors read and approved the final manuscript.

Authors’ original submitted files for images

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Maurel, S., Mougel, M. Murine leukemia virus RNA dimerization is coupled to transcription and splicing processes. Retrovirology 7, 64 (2010) doi:10.1186/1742-4690-7-64

Download citation

Keywords

  • Murine Leukemia Virus
  • Transcription Site
  • Direct Transcription
  • Nuclear Trafficking
  • Virus Assembly Site